VESALIUS-CV

Objective

The purpose of this study is to assess the effect of lowering low-density lipoprotein cholesterol (LDL-C) with evolocumab on major cardiovascular events in subjects without a prior MI or stroke at high risk of a cardiovascular event.

View this clinical trail on ClinicalTrials.gov.

Location:

Essentia Health East

Research Study Categories

  • Adult Studies

Specialty

  • Cardiology
Contact
Cardiology Clinical Trials at 866-839-4128
or clinicaltrials@essentiahealth.org

Like most websites, we use cookies and other technologies to keep our website reliable, secure, and to better understand how our site is used. By using our site, you agree to our use of these tools. Learn more.